Literature DB >> 17259196

Federal initiatives to support rapid learning about new technologies.

Sean R Tunis1, Tanisha V Carino, Reginald D Williams, Peter B Bach.   

Abstract

Health policy and financing reforms place increasing emphasis on the ability of doctors and patients to make informed, cost-conscious care decisions. The federal government is supporting new initiatives in Medicare to increase the supply of reliable information on the benefits and risks of health care technologies. Medicare also is working with the Agency for Healthcare Research and Quality (AHRQ) to evaluate the comparative effectiveness of prescription drugs and other items or services. The value of these efforts will depend on coordination among individuals and institutions in the public and private sectors; clarity about focus, purpose, and priorities; and adequate and reliable long-term funding.

Entities:  

Mesh:

Year:  2007        PMID: 17259196     DOI: 10.1377/hlthaff.26.2.w140

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  7 in total

1.  Medicare's Coverage With Evidence Development: A Policy-Making Tool in Evolution.

Authors: 
Journal:  J Oncol Pract       Date:  2007-11       Impact factor: 3.840

2.  Medicare's policy on carotid stents limited use to hospitals meeting quality guidelines yet did not hurt disadvantaged.

Authors:  Peter W Groeneveld; Andrew J Epstein; Feifei Yang; Lin Yang; Daniel Polsky
Journal:  Health Aff (Millwood)       Date:  2011-02       Impact factor: 6.301

3.  Access with evidence development schemes: a framework for description and evaluation.

Authors:  Christopher J McCabe; Tania Stafinski; Richard Edlin; Devidas Menon
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

4.  An evidence integration triangle for aligning science with policy and practice.

Authors:  Russell E Glasgow; Lawrence W Green; Martina V Taylor; Kurt C Stange
Journal:  Am J Prev Med       Date:  2012-06       Impact factor: 5.043

5.  Intended versus inferred management after PET for cancer restaging: analysis of Medicare claims linked to a coverage with evidence development registry.

Authors:  Bruce E Hillner; Tor D Tosteson; Anna N A Tosteson; Qianfei Wang; Yunjie Song; Tracy Onega; Lucy G Hanna; Barry A Siegel
Journal:  Med Care       Date:  2013-04       Impact factor: 2.983

6.  Life-science research within US academic medical centers.

Authors:  Darren E Zinner; Eric G Campbell
Journal:  JAMA       Date:  2009-09-02       Impact factor: 56.272

Review 7.  Who is responsible for evaluating the safety and effectiveness of medical devices? The role of independent technology assessment.

Authors:  Mitchell D Feldman; Amy J Petersen; Leah S Karliner; Jeffrey A Tice
Journal:  J Gen Intern Med       Date:  2008-01       Impact factor: 5.128

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.